OLR1 and liver dysplastic nodule: The study by Luo and colleagues (45) supplies important informations with regard to detection, Characterization, and monitoring of early DN, utilizing the interaction between LOX-1-enriched inflammatory renal lesions and anti-LOX-1 targeted nanoparticles.